Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T15:32:45.551Z.
Calculation as of: 2026-10-06T15:32:45.551Z.
Quote observation: 2026-10-06T15:29:51.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5811ce025d9976e80ea69b9f8bae613fc78d61205a97c72640e2bc4d521a59ba
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Eloxx Pharmaceuticals, Inc.
Market Cap
$52.37M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$52.53M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.45M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.33M
EV/EBITDA Ratio
N/A
TTM Avg
335.70x
3Y Avg
335.70x
5Y Avg
335.70x
Market Cap
$51.18M
EV/EBITDA Ratio
N/A
TTM Avg
35309.82x
3Y Avg
79402.66x
5Y Avg
79402.66x
Market Cap
$51.04M
EV/EBITDA Ratio
N/A
TTM Avg
310.55x
3Y Avg
191.07x
5Y Avg
171.86x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | $52.37M | N/A | N/A | N/A | N/A |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $52.53M | N/A | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.98M | N/A | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $51.83M | 9.10x | 5.34x | 6.36x | 5.55x |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.45M | N/A | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $51.39M | N/A | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | N/A | 335.70x | 335.70x | 335.70x |
| INmune Bio, Inc. (INMB)vs › | $51.18M | N/A | 35309.82x | 79402.66x | 79402.66x |
| Microbot Medical Inc. (MBOT)vs › | $51.04M | N/A | 310.55x | 191.07x | 171.86x |
| ImageneBio Inc (IMA)vs › | $54.25M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
